An assessment of predictive factors for overall survival in glioblastoma – MGMT methylation is solely important for younger patients

An assessment of predictive factors for overall survival in glioblastoma – MGMT methylation is solely important for younger patients

Bibliographic Details
Main Authors:	T. Cosar, A. Krigers, J. Kerschbaumer, M. Demetz, D. Pinggera, C. Thomé, C.F. Freyschlag
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Brain and Spine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772529422006361

Similar Items

Impact of GAP-43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas
by: A. Krigers, et al.
Published: (2022-01-01)

Correlation of Clinical Frailty Scale with IDH mutation and MGMT methylation in high-grade glioma
by: J. Klingenschmid, et al.
Published: (2021-01-01)

The Clinical Frailty Scale is superior to the Karnofsky Performance Status as predictor of overall survival in patients with surgical treatment of brain metastases
by: N. Pichler, et al.
Published: (2022-01-01)

Age-Dependent Impact of Concomitant Radio-Chemotherapy and MGMT Promotor Methylation on PFS and OS in Patients with IDH Wild-Type Glioblastoma: The Real-Life Data
by: Aleksandrs Krigers, et al.
Published: (2022-12-01)

The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
by: Aleksandrs Krigers, et al.
Published: (2022-06-01)

Now you see me - the use of sodium fluoresceine for resection of brain metastases
by: J. Kerschbaumer, et al.
Published: (2022-01-01)

The Clinical Frailty Scale as predictor of overall survival in high-grade glioma patients
by: J. Klingenschmid, et al.
Published: (2021-01-01)

Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide
by: Konstantin R. Brawanski, et al.
Published: (2023-03-01)

Association between <i>MGMT</i> Enhancer Methylation and <i>MGMT</i> Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
by: Katja Zappe, et al.
Published: (2023-06-01)

Impact of GAP-43, Cx43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas
by: Aleksandrs Krigers, et al.
Published: (2023-02-01)

Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma
by: Valentin Karl Ladenhauf, et al.
Published: (2023-02-01)

Cadaveric study of ergonomics and performance using a robotic exoscope with a head-mounted display in spine surgery
by: M. Demetz, et al.
Published: (2022-01-01)

Clinical Frailty Scale and Karnofsky Performance Status are Superior to Temporal Muscle Thickness in Survival Prediction in Brain Metastasis Patients
by: Aleksandrs Krigers, et al.
Published: (2023-01-01)

MGMT Methylation and Differential Survival Impact by Sex in Glioblastoma
by: Addison E. Barnett, et al.
Published: (2024-03-01)

DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma
by: Georges Chehade, et al.
Published: (2024-02-01)

Surgical Management of Malignant Glioma in the Elderly
by: Julia Klingenschmid, et al.
Published: (2022-05-01)

Glioblastoma and the significance of MGMT gene methylation
by: Payam Izadpanahi, et al.
Published: (2014-08-01)

Glioblastoma and the significance of MGMT gene methylation
by: Payam Izadpanahi, et al.
Published: (2014-08-01)

Tim-3 Expression and MGMT Methylation Status Association With Survival in Glioblastoma
by: Ji Zhang, et al.
Published: (2020-09-01)

Risk Factors for Radiation Necrosis in Patients Undergoing Cranial Stereotactic Radiosurgery
by: Johannes Kerschbaumer, et al.
Published: (2021-09-01)

The role of epilepsy in elderly patients with Glioblastoma: An Austrian multicenter analysis
by: Matthias Demetz, et al.
Published: (2023-01-01)

Age is associated with unfavorable neuropathological and radiological features and poor outcome in patients with WHO grade 2 and 3 gliomas
by: Aleksandrs Krigers, et al.
Published: (2021-08-01)

Surgeon's comfort: The ergonomics of a robotic exoscope using a head-mounted display
by: Anto Abramovic, et al.
Published: (2022-01-01)

Tumor Location Impacts the Development of Radiation Necrosis in Benign Intracranial Tumors
by: Matthias Demetz, et al.
Published: (2023-09-01)

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
by: Iliadis Georgios, et al.
Published: (2012-01-01)

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
by: Smrdel Uros, et al.
Published: (2016-12-01)

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients
by: Federico Cucchiara, et al.
Published: (2022-07-01)

Temporal muscle thickness has no prognostic relevance in patients with high-grade glioma compared to functional scales
by: Julia Klingenschmid, et al.
Published: (2023-08-01)

Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation status
by: Matos Bostjan, et al.
Published: (2018-11-01)

The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.
by: Chih-Yi Hsu, et al.
Published: (2017-01-01)

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
by: Magda Sayed Mahmoud, et al.
Published: (2024-03-01)

Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
by: Nelli S. Lakis, et al.
Published: (2022-11-01)

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
by: David Gibson, et al.
Published: (2024-03-01)

The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
by: Fatih Incekara, et al.
Published: (2020-07-01)

Sex Disparities in <i>MGMT</i> Promoter Methylation and Survival in Glioblastoma: Further Evidence from Clinical Cohorts
by: Anja Smits, et al.
Published: (2021-02-01)

Preoperative prediction of language function by diffusion tensor imaging
by: C. F. Freyschlag, et al.
Published: (2017-05-01)

The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
by: Huy Gia Vuong, et al.
Published: (2020-09-01)

MGMT promoter methylation correlates with an overall survival benefit in Chinese high-grade glioblastoma patients treated with radiotherapy and alkylating agent-based chemotherapy: a single-institution study.
by: Dong Shen, et al.
Published: (2014-01-01)

Influence of Intratumor Heterogeneity on the Predictivity of MGMT Gene Promoter Methylation Status in Glioblastoma
by: Giovanni Brigliadori, et al.
Published: (2020-10-01)

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma
by: Miyuki Uno, et al.
Published: (2011-01-01)